Covered recipient · General Payments record
STEVEN A TENENBAUM
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2019–2025
$3,899.85
- Reported across 121 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $336.10 | 11 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $118.75 | 1 |
| Corcept Therapeutics | $102.40 | 4 |
| Novo Nordisk AS | $45.30 | 2 |
| Lilly USA, LLC | $33.17 | 2 |
| EISAI INC. | $20.66 | 1 |
| Azurity Pharmaceuticals, Inc. | $15.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $118.75 | 12/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228292245 | CMS |
| Azurity Pharmaceuticals, Inc. | $15.82 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242680098 | CMS |
| Corcept Therapeutics | $24.59 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214234162 | CMS |
| Corcept Therapeutics | $28.11 | 10/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214234247 | CMS |
| Corcept Therapeutics | $29.80 | 11/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214234273 | CMS |
| Corcept Therapeutics | $19.90 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214234267 | CMS |
| Eisai Inc. | $20.66 | 01/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244514245 | CMS |
| Lilly USA, LLC | $15.76 | 07/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186869453 | CMS |
| Lilly USA, LLC | $17.41 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186848167 | CMS |
| Novo Nordisk Inc | $24.40 | 04/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189104107 | CMS |
| Novo Nordisk Inc | $20.90 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188309202 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.